Home / 2018 / January

Monthly Archives: January 2018




Jan. 30, 2018

I was with about 10 other riders at breakfast recently. I happened to hear the word “diabetes” and of course my ears perked up. When I asked Russ and Randy what they were talking about, the subject was food choices and insulin resistance. Seems that one of them had heard …

Read More »

International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #110: Type 2 Diabetes and Cancer Part 3

Dyslipidemia: The relationship between cholesterol and cancer risk has been difficult to discern from epidemiologic studies. Individuals with the metabolic syndrome and T2DM frequently have a dyslipidemic profile with elevated triglycerides and decreased high-density lipoprotein cholesterol (HDL-C). In the Metabolic Syndrome Cancer (Me-Can) European cohort elevated triglyceride levels were associated with colon, respiratory, kidney, thyroid cancers, and melanoma in men and respiratory, cervical, and nonmelanoma skin cancers in women.

Read More »

Jan. 27, 2018

The CDC and NIH are saying that this year is one of the worst ever for the flu. Patients often try OTC’s to treat the symptoms, but a lot of times respiratory problems drive them to their prescriber, and often a short course of tapering corticosteroid therapy is prescribed. This …

Read More »

How To Overcome The Complexities of Treatment Decisions For Your Patients with Type 2 Diabetes

Part 3: Trade Offs — Clinical Decision Making for Patients with Type 2 Diabetes: In the previous series of articles, we discussed the complexity of clinical decision making and the role the cost plays into that decision. Cost is only one dimension of the complex process of deciding the appropriate next steps in the treatment of type 2 diabetes. In this article, we will discuss the other aspects of clinical decision making, and how clinicians can think about the trade-offs involved in making medication choices.

Read More »